Regulation of the Atm promoter in vivo

Genes Chromosomes and Cancer

Volumn 45, Issue 1, 2006, Pages 61-71

  Gueven, Nuri ^a   Fukao, Toshiyuki ^a,b   Luff, John ^a   Paterson, Carol ^a   Kay, Graham ^a   Kondo, Naomi ^b   Lavin, Martin F ^a,c,d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b GIFU UNIVERSITY   (Japan)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ATM PROTEIN; GENOMIC DNA; LUCIFERASE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC DISORDER; HEAT STRESS; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE; TRANSGENE; WESTERN BLOTTING; WHOLE BODY RADIATION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAT SHOCK RESPONSE; MALE; PHOSPHORYLATION; PROMOTER REGION; RADIATION EXPOSURE; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALIA; ATAXIA TELANGIECTASIA; MURINAE; MUS; MUS MUSCULUS;

ANIMALS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HEAT-SHOCK RESPONSE; LUCIFERASES; MALE; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 33644932202     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20267     Document Type: Article

References (41)

1. Allen DM, van Praag H, Ray J, Weaver Z, Winrow CJ, Carter TA, Braquet R, Harrington E, Ried T, Brown KD, Gage FH, Barlow C. 2001. Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev 15:554-566.
2. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.
3. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171.
4. Barlow C, Ribaut-Barassin C, Zwingman TA, Pope AJ, Brown KD, Owens JW, Larson D, Harrington EA, Haeberle AM, Mariani J, Eckhaus M, Herrup K, Bailly Y, Wynshaw-Boris A. 2000. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci USA 97:871-876.
5. Barzilai A, Rotman G, Shiloh Y. 2002. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amsterdam) 1:23-25.
6. Barzilai A, Yamamoto K. 2004. DNA damage responses to oxidative stress. DNA Repair 3:1109-1115.
7. Boder E. 1975. Ataxia-telangiectasia: some historic, clinical and pathologic observations. In: Bergsma D, editor. Immunodeficiency in Man and Animals. New York: National Foundation-March of Dimes, pp. 255-300.
8. Boder E, Sedgwick RP. 1970. Ataxia-telangiectasia. (Clinical and immunological aspects). Psychiatr Neurol Med Psychol Beih 13-14:8-16.
9. Brown KD, Ziv Y, Sadanandan SN, Chessa L, Collins FS, Shiloh Y, Tagle DA. 1997. The ataxia telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci USA 94:1840-1845.
10. Cerutti P, Shah G, Peskin A, Amstad P. 1992. Oxidant carcinogenesis and antioxidant defense. Ann N Y Acad Sci 663:158-166.
11. Chen P, Peng C, Luff J, Spring K, Watters D, Bottle S, Furuya S, Lavin MF. 2003. Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice. J Neurosci 23:11453-11460.
12. Chen X, Yang L, Udar N, Liang T, Uhrhammer N, Xu S, Bay JO, Wang Z, Dandakar S, Chiplunkar S, Klisak I, Teletar M, Yang H, Concannon P, Gatti RA. 1997. CAND3: a ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 11q23.1. Mamm Genome 8:129-133.
13. Clarke RA, Kairouz R, Watters D, Lavin MF, Kearsley JH, Lee CS. 1998. Upregulation of ATM in sclerosing adenosis of the breast. Mol Pathol 51:224-226.
14. Cornforth MN, Bedford JS. 1985. On the nature of a defect in cells from individuals with ataxia telangiectasia. Science 227:1589-1591.
15. Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P. 1996. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Nat Acad Sci USA 93:13084-13089.
16. Fang ZM, Lee CS, Sarris M, Kearsley JH, Murrell D, Lavin MF, Keating K, Clarke RA. 2001. Rapid radiation-induction of ATM protein levels in situ. Pathology 33:30-36.
17. Foray N, Priestley A, Alsbeih G, Badie C, Capulas EP, Arlett CF, Malaise EP. 1997. Hypersensitivity of ataxia-telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double strand breaks. Int J Radiat Biol 72:271-283.
18. Fukao T, Kaneko H, Birrell G, Gatei M, Tashita H, Yoshida T, Cross S, Kedar P, Watters D, Khanna KK, Misko I, Kondo N, Lavin MF. 1999. ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells. Blood 94:1998-2006.
19. Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K. 1991. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine 70:99-117.
20. Gizang-Ginsberg E, Ziff EB. 1990. Nerve growth factor regulates tyrosine hydroxylase gene transcription through a nucleoprotein complex that contains c-Fos. Genes Dev 4:477-4791.
21. Gueven N, Keating K, Fukao T, Loeffler H, Kondo N, Rodemann HP, Lavin MF. 2003. Site-directed mutagenesis of the ATM promoter: consequences for response to proliferation and ionizing radiation. Genes Chromosomes Cancer 38:157-167.
22. Gueven N, Keating KE, Chen P, Fukao T, Khanna KK, Watters D, Rodemann PH, Lavin MF. 2001. Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasia. J Biol Chem 276:8884-8891.
23. Hirai Y, Hayashi T, Kubo Y, Hoki Y, Arita I, Tatsumi K. 2001. X-irradiation induces up-regulation of ATM gene expression in wild-type lymphoblastoid cell lines, but not in their heterozygous or homozygous ataxia-telangiectasia counterparts. Jpn J Cancer Res 92:710-717.
24. Imai T, Yamauchi M, Seki N, Sugawara T, Saito T, Matsuda Y, Ito H, Nagase T, Nomura N, Hori T. 1996. Identification and characterization of a new gene physically linked to the ATM gene. Genome Res 6:439-447.
25. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I. 2004. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431:997-1002.
26. Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, Barzilai A. 2001. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 61:1849-1854.
27. Keating KE, Gueven N, Watters D, Rodemann HP, Lavin MF. 2001. Transcriptional downregulation of ATM by EGF is defective in ataxia-telangiectasia cells expressing mutant protein. Oncogene 20:4281-4290.
28. Kim W-J, Vo QN, Shrivastav M, Lataxes TA, Brown KD. 2002. Abberant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 21:3864-3871.
29. Kozlov S, Gueven N, Keating K, Ramsay J, Lavin MF. 2003. ATP activates ATM in vitro: importance of autophosphorylation. J Biol Chem 278:9309-9317.
30. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AM, Jackson SP. 1996. Analysis of the ATM protein in wild-type and ataxia-telangiectasia cells. Oncogene 13:2707-2716.
31. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N. 2005. ATM signalling and genomic stability in response to DNA damage. Mutat Res 569:123-132.
32. Lavin MF, Shiloh Y. 1997. The genetic defect in ataxia-telangiectasia. Ann Rev Immunol 15:177-202.
33. McFarlin DE, Strober W, Waldmann TA. 1972. Ataxia-telangiectasia. Medicine (Baltimore) 51:281-314.
34. Reliene R, Fischer E, Schiestl RH. 2004. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res 64:5148-5153.
35. Sedgwick RP, Boder E. 1991. Ataxia-telangiectasia. In: Vianney De Jong JMB, Liss AR, editors. Hereditary Neuropathies and Spinocerebellar Attophies. New York: Elsevier. pp. 347-423.
36. Spring K, Cross S, Li C, Watters D, Ben-Senior L, Waring P, Ahangari F, Lu SL, Chen P, Misko I, Paterson C, Kay G, Smorodinsky NI, Shiloh Y, Lavin MF. 2001. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res 61:4561-4568.
37. Watters D, Khanna KK, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhang N, Farrell A, Ramsay J, Gatti R, Lavin MF. 1997. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14:1911-1921.
38. Weizman N, Shiloh Y, Barzilai A. 2003. Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains. J Biol Chem 278:6741-6747.
39. Westphal CH, Hoyes KP, Canman CE, Huang X, Kastan MB, Hendry JH, Leder P. 1998. Loss of atm radiosensitizes multiple p53 null tissues. Cancel Res 58:5637-5639.
40. Zhang HJ, Xu L, Drake VJ, Xie L, Oberley LW, Kregel KC. 2003a. Heat-induced liver injury in old rats is associated with exaggerated oxidative stress and altered transcription factor activation. FASEB J 17:2293-2295.
41. Zhang W, Purchio A, Chen K, Burns SM, Contag CH, Contag PR. 2003b. In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors. Biochem Pharmacol 65:1889-1896.